Table 6.

Results of Cytogenetic Analysis in 31 Cases of MCL

ResultNo. of Cases
t(11; 14)(q13; q32) present6-150 14 
t(11; 14)(q13; q32) absent, but karyotype abnormal 
Case no. 1: 43-44,X,−Y,der(3)t(3; ?)(p11; ?),t(8; 9)(q24; q13), der(9)t(9; 14)(q13; q32),−11,−15,del(14)(q23), der(17)t(3; 17)(q13; p11),−21,+mar[cp16] 
Case no. 2: 47,X,−Y,+3,add(14)(q32),+mar1,+mar2[7] 
Case no. 3 and 4: complex abnormal cell lines6-151 
Analysis unsuccessful6-152 13 
ResultNo. of Cases
t(11; 14)(q13; q32) present6-150 14 
t(11; 14)(q13; q32) absent, but karyotype abnormal 
Case no. 1: 43-44,X,−Y,der(3)t(3; ?)(p11; ?),t(8; 9)(q24; q13), der(9)t(9; 14)(q13; q32),−11,−15,del(14)(q23), der(17)t(3; 17)(q13; p11),−21,+mar[cp16] 
Case no. 2: 47,X,−Y,+3,add(14)(q32),+mar1,+mar2[7] 
Case no. 3 and 4: complex abnormal cell lines6-151 
Analysis unsuccessful6-152 13 
F6-150

Includes 1 case with complex disruption of both 11q13 and 14q32 but no clearly identifiable translocation.

F6-151

Patients with concurrent breast cancer in lymph node specimens. Abnormal karyotype is likely that of carcinoma.

F6-152

Specimens that failed to yield analyzable metaphases or yielded only normal metaphases from suboptimal tissue sites (eg, BM or PB).

or Create an Account

Close Modal
Close Modal